R. Bryant

Most-cited papers

1. Secreted cathepsin L generates endostatin from collagen XVIII

   U. Felbor, Lars Dreier, R. Bryant, H. Ploegh +2 more

   2000EMBO Journal466 citations Open access

   Semantic Scholar

   Save

2. Proteases involved in MHC dass II antigen presentation

   J. Villadangos, R. Bryant, J. Deussing, C. Driessen +8 more

   1999Immunological Reviews250 citations

   Semantic Scholar

   Save

3. Role for Cathepsin F in Invariant Chain Processing and Major Histocompatibility Complex Class II Peptide Loading by Macrophages

   G. Shi, R. Bryant, R. Riese, S. Verhelst +5 more

   2000Journal of Experimental Medicine244 citations Open access

   Semantic Scholar

   Save

4. Cathepsin S Controls the Trafficking and Maturation of Mhc Class II Molecules in Dendritic Cells

   C. Driessen, R. Bryant, A. Lennon-Duménil, J. Villadangos +4 more

   1999Journal of Cell Biology242 citations Open access

   Semantic Scholar

   Save

5. Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis

   J. Canon, M. Roudier, R. Bryant, S. Morony +3 more

   2007Clinical and Experimental Metastasis216 citations

   Semantic Scholar

   Save

6. Regulation of Murine Osteoblast Macrophage Colony-Stimulating Factor Production by 1,25(OH)2D3

   Janet E. Rubin, Fan Xian, D. Thornton, R. Bryant +1 more

   1996Calcified Tissue International62 citations

   Semantic Scholar

   Save

7. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model

   J. Canon, R. Bryant, M. Roudier, D. Branstetter +1 more

   2012Breast Cancer Research and Treatment42 citations

   Semantic Scholar

   Save

8. Inhibition of RANKL increases the anti-tumor effect of the EGFR inhibitor panitumumab in a murine model of bone metastasis.

   J. Canon, R. Bryant, M. Roudier, T. Osgood +5 more

   2010Bone42 citations

   Semantic Scholar

   Save

9. Abstract 3947: AMG 161, a fully human monoclonal antibody to human RANKL, inhibits tumor-induced osteoclastogenesis and reduces skeletal tumor burden in mice that express chimeric (murine / human) RANKL.

   J. Canon, R. Bryant, M. Roudier, W. Dougall

   20131 citations

   Semantic Scholar

   Save

10. P13. The RANKL inhibitor OPG-Fc delays the de novo establishment of breast cancer skeletal metastases in an MDA-MB-231 mouse model

    J. Canon, R. Bryant, Robert E. Miller, Ryan Erwert +3 more

    20081 citations

    Semantic Scholar

    Save

11. 549 POSTER The RANKL inhibitor osteoprotegerin (OPG) inhibits tumor growth, prevents tumor-induced osteolysis, and significantly improves survival in a mouse model of breast cancer bone metastasis

    J. Canon, M. Roudier, R. Bryant, R. Radinsky +1 more

    20060 citations

    Semantic Scholar

    Save